How deep we sleep can affect our brain’s ability to efficiently wash away waste and toxic proteins, new research suggests. Because sleep often becomes increasingly lighter and more disrupted as we get older, the study reinforces and potentially explains the links among aging, sleep deprivation, and heightened risk for Alzheimer’s disease. “Sleep is critical to the function of the brain’s waste removal system and this study shows that the deeper the sleep the better,” says Maiken Nedergaard, Co-Director of the Center for Translational Neuromedicine at the University of Rochester Medical Center (URMC) and lead author of the study. “These findings also add to the increasingly clear evidence that quality of sleep or sleep deprivation can predict the onset of Alzheimer’s and dementia.” The study, which appears in the journal Science Advances, indicates that the slow and steady brain and cardiopulmonary activity associated with deep non-REM sleep are optimal for the function of the glymphatic system, the brain’s unique process of removing waste. The findings may also explain why some forms of anesthesia can lead to cognitive impairment in older adults. Using eight-day diary data from a sample of 130 middle-aged workers in a U.S. IT firm, we found that a previous night’s sleep characteristics predicted next-day “cognitive interference,” or the experience of off-task and distracting thoughts. To measure this, we used a five-point frequency (0=never to 4=very often) and averaged responses on nine items that measure the experience of off-task and distracting thoughts than usual. For example, one of the questions was “How often did you have thoughts that kept jumping into your head today?”
WASHING AWAY WASTE
Nedergaard and her colleagues first described the previously unknown glymphatic system in 2012. Prior to that point, scientists didn’t fully understand how the brain, which maintains its own closed ecosystem, removed waste. The study revealed a system of plumbing which piggybacks on blood vessels and pumps cerebral spinal fluid (CSF) through brain tissue to wash away waste. A subsequent study showed that this system primarily works while we sleep. Because the accumulation of toxic proteins such as beta amyloid and tau in the brain are associated with Alzheimer’s disease, researchers have speculated that impairment of the glymphatic system due to disrupted sleep could be a driver of the disease. This squares with clinical observations which show an association between sleep deprivation and heightened risk for Alzheimer’s. In the current study, researchers conducted experiments with mice anesthetized with six different anesthetic regimens. While the animals were under anesthesia, the researchers tracked brain electrical activity, cardiovascular activity, and the cleansing flow of CSF through the brain. The team observed that a combination of the drugs ketamine and xylazine (K/X) most closely replicated the slow and steady electrical activity in the brain and slow heart rate associated with deep non-REM sleep. Furthermore, the electrical activity in the brains of mice administered K/X appeared to be optimal for the function of the glymphatic system. “The synchronized waves of neural activity during deep slow-wave sleep, specifically firing patterns that move from front of the brain to the back, coincide with what we know about the flow of CSF in the glymphatic system,” says Lauren Hablitz, a postdoctoral associate in Nedergaard’s lab and first author of the study. “It appears that the chemicals involved in the firing of neurons, namely ions, drive a process of osmosis which helps pull the fluid through brain tissue.”
The study raises several important clinical questions. It further bolsters the link between sleep, aging, and Alzheimer’s disease. Researchers have known that as we age it becomes more difficult to consistently achieve deep non-REM sleep, and this study reinforces the importance of deep sleep to the proper function of the glymphatic system. The study also demonstrates that enhancing sleep can manipulate the glymphatic system, a finding that may point to potential clinical approaches, such as sleep therapy or other methods to boost the quality of sleep, for at risk populations.
Furthermore, because several of the compounds used in the study were analogous to anesthetics used in clinical settings, the study also sheds light on the cognitive difficulties that older patients often experience after surgery and suggests classes of drugs that could help avoid this phenomenon. Mice in the study that researchers exposed to anesthetics that did not induce slow brain activity saw diminished glymphatic activity. “Cognitive impairment after anesthesia and surgery is a major problem,” says coauthor Tuomas Lilius with the Center for Translational Neuromedicine at the University of Copenhagen in Denmark. “A significant percentage of elderly patients that undergo surgery experience a postoperative period of delirium or have a new or worsened cognitive impairment at discharge.”
Mark Michaud, Associate Director of Communication, University of Rochester
This article is published in collaboration with Futurity.